This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


Jenrin Discovery, Inc

Drug Names(s): JD-5037

Description: JD-5037 is a peripherally selective (PS) inverse agonist of the CB1 receptor designed to minimize blood-brain barrier penetration and brain receptor interaction mediating the chief neuropsychiatric liability associated with first-generation brain penetrant CB1 receptor blockers.

Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug